Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 17
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
705
+0.25%
|
-
|
Dec 17
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
211
+0.35%
|
-
|
Dec 03
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
258
+0.2%
|
-
|
Dec 03
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
796
+0.29%
|
-
|
Dec 03
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
229
+0.38%
|
-
|
Dec 03
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
287
+0.42%
|
-
|
Dec 01
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
303
-0.51%
|
$3,636
$12.37 P/Share
|
Dec 01
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
591
-0.21%
|
$7,092
$12.37 P/Share
|
Dec 01
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
394
-0.91%
|
$4,728
$12.37 P/Share
|
Dec 01
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
466
-0.37%
|
$5,592
$12.37 P/Share
|
Dec 01
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
666
-0.98%
|
$7,992
$12.37 P/Share
|
Dec 01
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
394
-0.33%
|
$4,728
$12.37 P/Share
|
Nov 19
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
234
+0.39%
|
-
|
Nov 19
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
826
+0.3%
|
-
|
Nov 19
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
267
+0.21%
|
-
|
Nov 19
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
298
+0.44%
|
-
|
Nov 13
2023
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
97
-0.14%
|
$970
$10.66 P/Share
|
Nov 13
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
132
-0.05%
|
$1,320
$10.77 P/Share
|
Nov 13
2023
|
Geraint Phillips SVP, Global Operations |
SELL
Open market or private sale
|
Direct |
111
-0.19%
|
$1,110
$10.66 P/Share
|
Nov 13
2023
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
98
-0.08%
|
$980
$10.77 P/Share
|
Nov 13
2023
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
76
-0.17%
|
$760
$10.77 P/Share
|
Nov 13
2023
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
114
-0.09%
|
$1,140
$10.77 P/Share
|
Nov 05
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
924
+0.33%
|
-
|
Nov 05
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
333
+0.49%
|
-
|
Nov 05
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
262
+0.44%
|
-
|
Nov 05
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
299
+0.24%
|
-
|
Nov 01
2023
|
Timothy L. Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
495
+2.59%
|
-
|
Nov 01
2023
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
598
+1.99%
|
-
|
Nov 01
2023
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
495
+1.54%
|
-
|
Nov 01
2023
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
577
+1.9%
|
-
|
Nov 01
2023
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
608
+1.83%
|
-
|
Oct 30
2023
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
72,603
-17.3%
|
$653,427
$9.13 P/Share
|
Oct 22
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
373
+0.55%
|
-
|
Oct 22
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,034
+0.37%
|
-
|
Oct 22
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
771
+0.18%
|
-
|
Oct 22
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
291
+0.49%
|
-
|
Oct 22
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
335
+0.27%
|
-
|
Oct 19
2023
|
Garrie Richardson Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,320
+25.64%
|
-
|
Oct 19
2023
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
394,856
+47.15%
|
-
|
Oct 19
2023
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
927,165
+9.78%
|
$10,198,815
$11.19 P/Share
|
Oct 08
2023
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
281
+0.42%
|
-
|
Oct 08
2023
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
282
+0.07%
|
-
|
Oct 08
2023
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
252
+0.2%
|
-
|
Oct 08
2023
|
Geraint Phillips SVP, Global Operations |
BUY
Grant, award, or other acquisition
|
Direct |
219
+0.37%
|
-
|
Oct 08
2023
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
779
+0.28%
|
-
|
Oct 01
2023
|
Timothy L. Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
362
+1.96%
|
-
|
Oct 01
2023
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
362
+0.79%
|
-
|
Oct 01
2023
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
362
+1.15%
|
-
|
Oct 01
2023
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
422
+1.42%
|
-
|
Oct 01
2023
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
445
+1.37%
|
-
|